Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT05929911
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Trauma-focused psychodynamic psychotherapy — BEHAVIORALThis psychotherapy addresses disruptions in the ability to reflect and affective regulation by exploring the psychological meanings of symptoms and their relation to traumatic events. The therapist works to identify intrapsychic conflicts, intense negative affects, and defense mechanisms related to the PTSD syndrome using a psychodynamic formulation that provides a framework for intervention. The transference provides a forum for patients to address feelings of mistrust, difficulties with authority, fears of abuse, angry and guilty feelings, and fantasies. This treatment will be provided in-person or over teletherapy as the public health situation demands.
Study Details
People living with HIV (PLWH) have a higher rate of post-traumatic stress disorder (PTSD) diagnosis than the general population. Comorbid PTSD is also associated with negative HIV-related health outcomes. Unfortunately, little outcome research has examined the usefulness of PTSD treatments for PTSD. This pilot study adapts for PLWH a non-exposure based psychotherapy for PTSD focused on reflecting on one's emotions and relationships and understanding and working through how trauma may have disrupted them. The study team is interested in better understanding the needs of PLWH with PTSD, learning whether PLWH with PTSD find this treatment acceptable and helpful, and beginning to understand the relationship between HIV-related health factors (e.g., inflammation and stress biology) and PTSD, and how these health factors may improve during treatment.
Key Dates
- Start date
- Apr 26, 2024
- Status verified
- Jun 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Trauma-focused psychodynamic psychotherapyTwice-weekly psychotherapy for 24 sessions
Primary Outcome Measure
Change in PTSD Score based on the Clinician Administered PTSD Scale for DSM-5 [ Time Frame: Baseline ]
Central Contacts
- John R Keefe, PhD703-981-7184
- Barbara L Milrod, MD917-593-1377
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | Barbara L Milrod, MD Barbara L Milrod, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in The Bronx, NY
Related Studies
- Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSDPHASE2 · Recruiting · NYU Langone Health · New York, New York
- Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIVPHASE1/PHASE2 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBIPHASE2 · Recruiting · NYU Langone Health · New York, New York
- Department of Defense PTSD Adaptive Platform Trial - Master ProtocolPHASE2 · Recruiting · Global Coalition for Adaptive Research · Miami, Florida